poisar

Filings · News reference

Mangoceuticals, Inc. Files Preliminary Proxy Statement and Current Report

Fiscal.ai

Mangoceuticals, Inc. submitted a preliminary proxy statement (Form PRE 14A) and a current report (Form 8-K) to the SEC on November 6, 2026.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K filing — MANGOCEUTICALS, INC. (MGRX)

    Filed: 2026-11-13 AccNo: 0001493152-26-051858 Size: 251 KB Item 3.03: Material Modifications to Rights of Security Holders Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and Exhibits